| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 May 25 | PRME Prime Medicine | Common Stock | Buy | Acquire P | No | No | 1.1772 | 125,000 | 147.15 k | 125,000 |
| 19 May 25 | PRME Prime Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 1.335 | 2,000,000 | 2.67 mm | 2,000,000 |
| 8 May 25 | PRME Prime Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 6.8 | 75,000 | 510.00 k | 850,000 |
| 27 Feb 25 | PRME Prime Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 2.42 | 275,000 | 665.50 k | 275,000 |
| 5 Dec 24 | PRME Prime Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 6.8 | 75,000 | 510.00 k | 775,000 |
